Physicians' Academy for Cardiovascular Education

Cholesterol Lowering and CV Risk: Meta-analyses

Slides (presentation) - Dec. 22, 2012

Slide lecture program (10 slides): View & Download

  1. On-Treatment LDL and CHD Events in Statin Trials
  2. Second Cycle of the CTT Meta-analysis: Proportional Effects on Major Vascular Events
  3. Second Cycle of the CTT Meta-analysis: More vs Less Statin
  4. Second Cycle of the CTT Meta-analysis: Statin vs Control
  5. Meta-analysis of Statin Trials and Fatal and Nonfatal Stroke
  6. Meta-analysis of Statin Trials and Stroke Mortality
  7. Stroke Risk and LDL Lowering in Statin Trials
  8. Second Cycle of the CTT Meta-analysis: Proportional Effects on Cause-Specific Mortality
  9. Meta-analysis of Statin Trials: Effect of Intensive LDL-C Lowering vs Standard Statin Therapy on Fatal and Nonfatal Stroke

Click on slides to preview

Download slides below

Cholesterol Lowering and CV Risk: Meta-analyses
On-Treatment LDL and CHD Events in Statin Trials
Second Cycle of the CTT Meta-analysis
Second Cycle of the CTT Meta-analysis: More vs Less Statin
Second Cycle of the CTT Meta-analysis: Statin vs Control
Meta-analysis of Statin Trials and Fatal and Nonfatal Stroke
Meta-analysis of Statin Trials and Stroke Mortality
Stroke Risk and LDL Lowering in Statin Trials
Second Cycle of the CTT Meta-analysis
Meta-analysis of Statin Trials: Effect of Intensive LDL-C

Share this page with your colleagues and friends: